Back to Trade & Investment

Trade & Investment Track

THE STRATEGIC OPPORTUNITY

Africa's healthcare sector requires innovative financing, scalable partnerships, and commercially viable solutions capable of transforming healthcare delivery.

The Kenya-UK Bilateral Health Financing Deal Room bridges this gap - bringing together capital, innovation, and political will at the highest level.

Key Indicator Significance
GBP 2.1 billion - 2020-2025 Total UK-Kenya trade in goods and services (four quarters to Q4 2025)
GBP 5 billion Target by 2030
GBP 91 million KEMRI-University of Oxford Wellcome Trust partnership (7-year grant)
GBP 25 million SAMBAI Cancer Grand Challenges Consortium (2024-2029)
480+ nurses Kenyan nurses placed in the UK National Health Service through KUKHA
70%+ Medicines currently imported across Africa - the manufacturing gap to close
51 businesses UK companies and personnel invited for the KUKHA conference 2026

Why Kenya, Why Healthcare, Why Now

Investment Logic Implication for Capital
Healthcare demand is expanding rapidly Private capital can support scalable care models, diagnostics, data, infrastructure and supply chains across a growing middle-class market
Policy and partnership momentum is strong Government alignment improves credibility for PPPs and institutional projects; President Ruto is the AU Champion for Local Manufacturing
Africa remains import-dependent (70%+ of medicines) Local manufacturing and technology transfer offer strong strategic upside with government policy tailwind
Kenya has research and talent depth KEMRI, universities, hospitals and UK partners create a strong innovation base with established clinical trial infrastructure
UK-Kenya bilateral trade at GBP 2.1 billion Commercial corridor with proven business flows, EPA framework and diplomatic support from BHC/DBT
51 UK businesses attending KUKHA 2026 Active corporate pipeline for trade, partnership and co-investment conversations